Drug Topics January 2020

January 21, 2020

Quality, speed, and price has been referred to as the "Unattainable Triangle".

January 21, 2020

Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.

January 20, 2020

As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade. 

January 20, 2020

Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.

January 17, 2020

Let’s take a look at some of the most common issues pharmacists are facing, as seen recently on Facebook.

January 17, 2020

Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications. 

January 16, 2020

Here are 4 pharmacy-related New Year’s resolutions that can help enhance your pharmacy services.

January 15, 2020

The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.

January 15, 2020

Progress has been made, but there’s still a long road ahead.

January 14, 2020

Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.

January 13, 2020

Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.

January 13, 2020

Here are the top drugs expected to be approved this year.

December 09, 2019

RDTs can improve outcomes and reduce unnecessary antibiotic use. 

December 09, 2019

Results from a poster at ASHP 2019.